Skip to menu Skip to content Skip to footer

2017

Conference Publication

Comparison of chemoradiotherapy (CRT) using carboplatin/paclitaxel (CP) versus cisplatin/5-FU (CF) for esophageal or gastroesophageal junctional (GEJ) cancer

Sim, Hao-Wen, Chan, Bryan Anthony, Natori, Akina, Lim, Charles Henry, Jiang, Di Maria, Moignard, Stephanie, Chen, Eric Xueyu, Liu, Geoffrey, Darling, Gail Elizabeth, Swallow, Carol Jane, Brar, Savtaj Singh, Brierley, James D., Ringash, Jolie, Wong, Rebecca, Kim, John, Rogalla, Patrik, Hafezi-Bakhtiari, Sara, Knox, Jennifer J., Jang, Raymond Woo -Jun and Elimova, Elena (2017). Comparison of chemoradiotherapy (CRT) using carboplatin/paclitaxel (CP) versus cisplatin/5-FU (CF) for esophageal or gastroesophageal junctional (GEJ) cancer. 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, Spain, 8 - 12 September 2017. Alexandria, VA, United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2017.35.15_suppl.4053

Comparison of chemoradiotherapy (CRT) using carboplatin/paclitaxel (CP) versus cisplatin/5-FU (CF) for esophageal or gastroesophageal junctional (GEJ) cancer

2017

Conference Publication

Comparison of chemoradiotherapy (CRT) with carboplatin/paclitaxel (CP) versus cisplatin/5-FU (CF) for esophageal or junctional cancer: Experience from the Princess Margaret Cancer Centre

Sim, Hao-Wen, Chan, Bryan, Natori, Akina, Lim, Charles Henry, Jiang, Di Maria and Chen, Eric Xueyu (2017). Comparison of chemoradiotherapy (CRT) with carboplatin/paclitaxel (CP) versus cisplatin/5-FU (CF) for esophageal or junctional cancer: Experience from the Princess Margaret Cancer Centre. 53rd Annual Clinical Meeting of the American Society of Clinical Oncology (ASCO), Chicago, IL United States, 2-7 June 2017. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2017.35.4_suppl.126

Comparison of chemoradiotherapy (CRT) with carboplatin/paclitaxel (CP) versus cisplatin/5-FU (CF) for esophageal or junctional cancer: Experience from the Princess Margaret Cancer Centre

2016

Conference Publication

Systematic review of interventions to facilitate advance care planning (ACP) in cancer patients

Chan, Bryan, Sim, Hao-Wen, Zimmermann, Camilla and Krzyzanowska, Monika K. (2016). Systematic review of interventions to facilitate advance care planning (ACP) in cancer patients. ASCO Annual Meeting, -, -. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2016.34.26_suppl.21

Systematic review of interventions to facilitate advance care planning (ACP) in cancer patients

2016

Conference Publication

Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand)

Chan, B. A., Sim, H-W., Ravikumar, A., Bailey, D., Chan, D., Lawrence, B., McEwan, A., Pavlakis, N., Segelov, E., Singh, S., Roach, P. and Wyld, D. (2016). Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand). Oxford, United Kingdom: Oxford University Press.

Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand)

2014

Conference Publication

Rural Oncology Care Via Teleoncology and Outreach Clinics: Patient and Staff Perspectives and Comparisons

Wyeth, Holly, Chan, Bryan, Burge, Matthew, Wyld, David and Eastgate, Melissa (2014). Rural Oncology Care Via Teleoncology and Outreach Clinics: Patient and Staff Perspectives and Comparisons. COSA's 41st Annual Scientific Meeting. Joining Forces - Accelerating Progress, Melbourne, VIC Australia, 2-4 December 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12305

Rural Oncology Care Via Teleoncology and Outreach Clinics: Patient and Staff Perspectives and Comparisons

2014

Conference Publication

Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyrapone

Chan, B. A., Wyld, D., Burge, M., Cuneo, R., Macfarlane, D. and Lee, K. (2014). Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyrapone. 11th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, 5 - 7 March 2014. Basel, Switzerland: S. Karger AG.

Success with Lutetium-177 DOTATATE therapy in Cushing's syndrome caused by functional pancreatic neuroendocrine tumor (pNET) with ectopic adrenocorticotropic hormone (ACTH) secretion refractory to concomitant everolimus, pasireotide and metyrapone

2012

Conference Publication

Safety of tele-oncology and chemotherapy delivery in rural centres

Chan, Bryan A. and Sabesan, Sabe (2012). Safety of tele-oncology and chemotherapy delivery in rural centres. Joint Meeting of the COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho–Oncology, Brisbane, QLD Australia, 13 - 15 November 2012. Hoboken, NJ United States: Wiley-Blackwell.

Safety of tele-oncology and chemotherapy delivery in rural centres